0
Nemaura Medical Inc. Banner Image

Nemaura Medical Inc. has reached its limit for free report views

Work for Nemaura Medical Inc.? Upgrade Your Profile and unlock all your annual reports.

Nemaura Medical Inc.

  • Ticker NMRD
    Exchange NASDAQ More
  • Industry Medical Appliances & Equipment More
  • Sector Healthcare More
Nemaura Medical Inc. Logo Image
  • 11-50 Employees
  • Based in New York City, New York
Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT®, BEAT™diabetes, and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucoseMore measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT® to the U.S. FDA. proBEAT™ combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service and is expected to be launched in the U.S. as a general wellness product.
Nemaura Medical Inc.

Most Recent Annual Report

Nemaura Medical Inc. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Nemaura Medical Inc. has reached its limit for free report views.

Older/Archived Annual Reports